Filter News
Area of Research
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (2)
- (-) Coronavirus (1)
- (-) Isotopes (2)
- (-) Materials Science (4)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (1)
- Artificial Intelligence (1)
- Big Data (1)
- Biology (1)
- Biotechnology (1)
- Clean Water (1)
- Composites (1)
- Computer Science (1)
- Decarbonization (1)
- Environment (1)
- Fossil Energy (1)
- High-Performance Computing (1)
- Machine Learning (1)
- Materials (5)
- Molten Salt (1)
- Nanotechnology (2)
- Neutron Science (22)
- Nuclear Energy (5)
- Physics (2)
- Space Exploration (1)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
How do you get water to float in midair? With a WAND2, of course. But it’s hardly magic. In fact, it’s a scientific device used by scientists to study matter.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
ORNL has entered a strategic research partnership with the United Kingdom Atomic Energy Authority, or UKAEA, to investigate how different types of materials behave under the influence of high-energy neutron sources. The $4 million project is part of UKAEA's roadmap program, which aims to produce electricity from fusion.
A scientific instrument at ORNL could help create a noninvasive cancer treatment derived from a common tropical plant.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.